ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,580.94
-1.97%
US Tech 100
18,676.00
-3.06%
Dow Jones
41,583.90
-1.69%
Brent Oil
72.43
-0.49%
Bitcoin
81,721.05
-0.76%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Windtree Therapeutics Inc (WINT)

  7. Windtree Therapeutics Inc (WINT) News

Windtree Therapeutics Inc

Windtree Therapeutics Inc (WINT)

NASDAQ
1.56
-0.08
(-4.88%)
Closed March 31 4:00PM
Delayed by 15 minutes
1.5001
-0.0599
(-3.84%)
After Hours: 7:51PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

WINT News

Official News Only

Form 8-K/A - Current report: [Amend]
Edgar (US Regulatory)
March 25 2025
WINT (-4.88%)

Form 8-K - Current report
Edgar (US Regulatory)
March 24 2025
WINT (-4.88%)

Form 8-K - Current report
Edgar (US Regulatory)
February 03 2025
WINT (-4.88%)

Form 8-K - Current report
Edgar (US Regulatory)
January 13 2025
WINT (-4.88%)
Windtree Therapeutics
WINT
Rendering Error

WINT Financials

Financials
Rendering Error

WINT Discussion

View Posts
nowwhat2 nowwhat2 6 days ago
Did somebody mention rveginas ?
👍️0
makinezmoney makinezmoney 6 days ago
$WINT: Who doesn't love Vaginal News

Am I right Ladies ???


GO $WINT
👍️0
glenn1919 glenn1919 7 days ago
WINT...................................................https://stockcharts.com/h-sc/ui?s=WINT&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 7 days ago
Vaginal news followed up by compliance news this morning  $3.55 + 40% . Be wise low float 800k but offering comes eventually 
👍️0
glenn1919 glenn1919 1 week ago
WINT.......................................https://stockcharts.com/h-sc/ui?s=WINT&p=W&b=5&g=0&id=p86431144783
👍️0
gapole gapole 1 week ago
Power hour...wint at 2.16...will it get pumped at eod??
👍️0
makinezmoney makinezmoney 2 weeks ago
$WINT: We're going to $5 before EOD

You heard it here first....................... Don't be scared now


GO $WINT
👍️0
makinezmoney makinezmoney 2 weeks ago
$WINT; $3.40 babyyyyyyyyyyyyyyyyyyyyyyyyy

Whos havin a good time............ talk to me now


GO $WINT
👍️0
makinezmoney makinezmoney 2 weeks ago
$WINT: Bring on the $3 breaker baby


You know you wannnnaaaaaaaaaaaaaaaaaaaaaaaa

Do it for DADDY


GO $WINT
👍️0
makinezmoney makinezmoney 2 weeks ago
$WINT: Now 2.70 ....................

Holla back if you making money off my CALLOUTS !!!!!!!!!!!!!!!

Love to hear from you.

Keep on ROcking in the Free World............ while its still a Free World




GO $WINT
👍️0
glenn1919 glenn1919 2 weeks ago
WINT.........................https://stockcharts.com/h-sc/ui?s=WINT&p=W&b=5&g=0&id=p86431144783
👍️0
makinezmoney makinezmoney 2 weeks ago
$WINT: Going on News...............




GO $WINT
👍️0
makinezmoney makinezmoney 2 weeks ago
$WINT: The bottom is in............ look at 200day chart

Shes gonna get to $3 today

GO $WINT
👍️0
makinezmoney makinezmoney 2 weeks ago
$WINT: BOoommmmmmmmmmmm.... now $2.20

Thar she blowwwwwwwwwssssssssssssss


GO $WINT
👍️0
glenn1919 glenn1919 4 weeks ago
WINT........................................................................https://stockcharts.com/h-sc/ui?s=WINT&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 1 month ago
WINT EXPLOSION
👍️ 1
TrendTrade2016 TrendTrade2016 1 month ago
WINT POST SPLIT MOVE
👍️0
Monksdream Monksdream 1 month ago
WINT, new 52 week low
👍️ 1
getmoreshares getmoreshares 1 month ago
RS info -1 for 50- feb 20--Windtree Therapeutics, Inc. (NasdaqCM: WINT) (“Windtree” or the “Company”), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, announces that its board of directors has approved a 1-for-50 reverse stock split of the Company’s common stock. The Company’s stockholders approved the reverse stock split proposal at the Company’s Special Meeting of Stockholders held on February 3, 2025. The stockholders granted the board of directors the authority to determine the exact split ratio and when to proceed with the reverse stock split.
The reverse stock split will become effective on February 20, 2025 at 5:00 p.m., Eastern Time (the “Effective Time”), and the Company’s common stock is expected to begin trading on a reverse stock split-adjusted basis on The Nasdaq Capital Market (“Nasdaq”) on February 21, 2025 at market open under the existing ticker symbol, “WINT.” The reverse stock split is intended to increase the price per share of the Company’s common stock to allow the Company to demonstrate compliance with the $1.00 minimum bid price requirement for continued listing on Nasdaq, among other benefits.
👍️0
big bambino big bambino 2 months ago
big uptick on GNS also 😅
👍️0
big bambino big bambino 2 months ago
nice move 😁
👍️0
glenn1919 glenn1919 2 months ago
WINT.............................................https://stockcharts.com/h-sc/ui?s=WINT&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 2 months ago
.2530 + 58%
👍️0
valleybenedetto valleybenedetto 2 months ago
Jumped in today .125 heavy
👍️0
getmoreshares getmoreshares 2 months ago
great site- thanks RS 5 to 50 Vote Approved
👍️0
bigbux1 bigbux1 2 months ago
Scroll 9 down...https://dilutiontracker.com/app/reverse-split
👍️0
getmoreshares getmoreshares 2 months ago
RS approved- no ratio announced yet
👍️0
BigJuan BigJuan 2 months ago
$WINT Hmm reversal here starting? Maybe run before 2/3 meeting.
👍️0
big bambino big bambino 2 months ago
checked for reason on surge and nothing visible, even on website
👍️0
Mr. Zen Mr. Zen 3 months ago
today announced that Alexandre Mebazaa, MD, one of the world’s recognized leaders in cardiogenic shock, gave a well-received presentation highlighting the data on istaroxime from the recently completed Phase 2b SEISMiC B study in early cardiogenic shock due to heart failure. The presentation was given at the Cardiovascular Clinical Trials Conference in Washington, DC.

Dr. Alexandre Mebazaa is Professor of Medicine at Université Paris Cité (France), Chair of Department of Anesthesia & Critical Care and an expert in heart failure and cardiogenic shock. He is part of the task force that wrote the 2021 ESC/HFA Guidelines of Heart Failure and the 2023 addendum.
👍️ 1 🚀 1
Monksdream Monksdream 4 months ago
WINT, new 52 low
👍️0
Monksdream Monksdream 5 months ago
WINT 10Q due 11/11
👍️0
Mr. Zen Mr. Zen 5 months ago
Took another position here, this could very easily be a $30.00 stock in 2 years, patience pays.
👍️ 1
tw0122 tw0122 5 months ago
Ping pong .80s to $1s
👍️0
Mr. Zen Mr. Zen 5 months ago
This may be the bottom for a longer term play,if they are successful with phase three it will be a $30.00 +/- stock. IMO
👍 2
glenn1919 glenn1919 5 months ago
WINT.....................................https://stockcharts.com/h-sc/ui?s=WINT&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 5 months ago
WINT take smaller gain .94s to $1.20 exit having trouble on bigger breakout to $1.40s
👍️0
tw0122 tw0122 5 months ago
1.11 test again
👍️0
tw0122 tw0122 5 months ago
WINT $1.11 breakout solid and $1.44
Up next 3m floater
👍️0
Mr. Zen Mr. Zen 5 months ago
Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced the issuance of an istaroxime patent for Japan. The patent is entitled, “Istaroxime-containing intravenous formulation for the treatment of heart failure (AHF).” The claims are directed to intravenous administration of istaroxime using increased infusion times alone or in combination with other agents useful to treat AHF, thereby improving treatment of heart failure and diastolic relaxation when compared to conventional protocols. The application has been accorded Patent No. 7560134 with a registration date of September 24, 2024 and will expire in 2039.
👍️0
Monksdream Monksdream 6 months ago
WINT new 52 week low
👍️0
Monksdream Monksdream 6 months ago
WINT new 52=week low
👍️0
Roadtojourney Roadtojourney 6 months ago
Yup they pr only to dilute there share pos?? Imo
👍️0
Mr. Zen Mr. Zen 6 months ago
Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced the trial design of its SEISMiC Phase 2b has been published by the European Society of Cardiology Heart Failure. The article is entitled, “Safety and efficacy of up to 60 hours of intravenous istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trial.” It can be found online in Wiley Online Library DIO: 10.1002/ehf2.15102. Results can be viewed at https://ir.windtreetx.com/corporate-presentation. The Heart Failure Society of America also shared the results.
👍️0
tw0122 tw0122 6 months ago
$1.26 + 36%
👍️0
tw0122 tw0122 6 months ago
Pump it
👍️0
Monksdream Monksdream 6 months ago
WINT anew 52 week low
👍️0
Monksdream Monksdream 6 months ago
WINT under $2
👍️0
Mr. Zen Mr. Zen 6 months ago
Windtree Announces Positive Phase 2b Topline Clinical Results with Istaroxime Significantly Improving Cardiac Function and Blood Pressure in Heart Failure Patients in Early Cardiogenic Shock
👍️ 1
Monksdream Monksdream 6 months ago
WINT new 52 week low
👍️0

Your Recent History

NASDAQ
WINT
Windtree Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads